• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING PHARMACEUTICALS INC. EUFLEXXA INJECTION FOR KNEE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING PHARMACEUTICALS INC. EUFLEXXA INJECTION FOR KNEE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Edema (1820); Emotional Changes (1831); Pain (1994)
Event Date 10/21/2020
Event Type  Injury  
Event Description
After my euflexxa injection in tight knee the pain is excruciating.My knee burns, edema, developed such swelling fluid cysts developed deep in knee.Had torn meniscus remove year prior and was getting steroid injection which were helping.Dr recommended a better injection euflexxa for long relief.Well after the injection of euflexxa i can hardly walk.The pain so bad i want to end life at time cant sleep.The pain traveling into hip and low back from knee edema and pain.I thought this was supposed to provide longterm solution to steroids which were ok.This is affecting my job, what i do at home, i am now battling constant level 11 pain daily.Can't this stuff be drained from my knee.I am extremely upset and now worried about walking again.This is unacceptable to do this to anyone.Is there any solution to this severe pain and edema with severe mobility issues.Thank you.Please warn others about this what i consider nasty and debilitating medication.No stopped refused more injections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA INJECTION FOR KNEE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING PHARMACEUTICALS INC.
MDR Report Key10831383
MDR Text Key215989022
Report NumberMW5097816
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator No Information
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/12/2020
Patient Sequence Number1
Treatment
CALCIUM ; HYDROCORTISONE ; IBUPROFEN AS NEEDED; MAGNESIUM ; VIT C
Patient Outcome(s) Disability;
Patient Age59 YR
Patient Weight90
-
-